Edition:
United States

Qiagen NV (QGEN.DE)

QGEN.DE on Xetra

23.77EUR
23 Sep 2016
Change (% chg)

€0.04 (+0.15%)
Prev Close
€23.74
Open
€23.90
Day's High
€23.91
Day's Low
€23.59
Volume
216,591
Avg. Vol
414,774
52-wk High
€25.54
52-wk Low
€17.76

QGEN.DE

Chart for QGEN.DE

About

QIAGEN N.V. (QIAGEN) is a holding company. The Company and its subsidiaries are engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Sample to Insight solutions are composed of sample and assay technologies, bioinformatics and automation systems. Its bioinformatics solutions... (more)

Overall

Beta: 0.52
Market Cap(Mil.): €5,694.73
Shares Outstanding(Mil.): 239.71
Dividend: --
Yield (%): --

Financials

  QGEN.DE Industry Sector
P/E (TTM): 53.35 42.52 36.60
EPS (TTM): 0.44 -- --
ROI: 3.06 -0.26 13.91
ROE: 4.59 -3.05 14.82

Judge blocks sales of Qiagen gene-sequencing device

A federal judge has ordered diagnostics technology company Qiagen NV to stop selling its new GeneReader gene-sequencing device, finding that rival Illumina Inc was likely to win a patent infringement lawsuit over the device.

Sep 13 2016

BRIEF-Qiagen to return $250 mln to shareholders

* Qiagen announces plans to return approximately $250 million to shareholders via synthetic share repurchase proposal Source text for Eikon: Further company coverage:

Aug 14 2016

German stocks - Factors to watch on August 1

FRANKFURT, Aug 1 The DAX top-30 index looked set to open 1.1 percent higher on Monday, according to premarket data from brokerage Lang & Schwarz at 0638 GMT.

Aug 01 2016

BRIEF-Qiagen Q2 adjusted earnings per share $0.24

July 28 Qiagen Reports Results For Second Quarter Of 2016 * Increased Commitment To Return $300 Million Of Capital To Shareholders By End 2017

Jul 28 2016

BRIEF-QIAGEN offer for Exiqon completed

* Announcement of the final result of the offer and completion thereof

Jun 23 2016

German stocks - Factors to watch on June 21

FRANKFURT, June 21 The DAX top-30 index looked set to open 0.1 percent higher on Tuesday, according to premarket data from brokerage Lang & Schwarz at 0612 GMT.

Jun 21 2016

BRIEF-MDxHealth grants Qiagen rights to MSP technology

* Grants Qiagen rights to MSP technology for qiasure methylation test for cervical cancer risk

Jun 15 2016

BRIEF-Exiqon: QIAGEN lowers offer condition and extends offer period

* QIAGEN lowers offer condition and extension of the offer period

Jun 08 2016

BRIEF-Exiqon: second extension of the Offer Period and the preliminary result of the Offer

* Preliminary and non-binding counting of acceptances shows that Qiagen in total has received acceptances from shareholders in Exiqon representing 89.21 pct of share capital and voting rights in Exiqon

Jun 03 2016

BRIEF-CareDx and QIAGEN enter into commercial collaboration

* Caredx and QIAGEN enter into commercial collaboration to enhance HLA lab experience using Qiaxcel instrumentation and Caredx HLA typing technology

May 31 2016

Earnings vs. Estimates